Ep 160 [08 January 2025]: Christer Nilsson – Objective Evidence: Wearables Redefine Clinical Studies

Ep 160 [08 January 2025]: Christer Nilsson, CEO of Replior and serial entrepreneur – We discussed Christer's fascinating career journey and background ... then we discussed the evolving transition to sensor-based measurements, representing a fundamental transformation in data access and quality. Instead of relying on traditional Patient Reported Outcomes (PROs) that capture subjective experiences ("How often did you scratch today?" or "What was your sun exposure level?"), sensors provide objective, quantifiable measurements of actual behavior. This Device Reported Outcome (DRO) shift eliminates significant inherent bias and reliability issues associated with self-reported data, replacing subjective "feelings-based" information with precise, automated measurements to support diverse clinical research study designs.

Disclaimer: The views expressed in this podcast are the guest's and host's alone, and do not reflect the official position of any organization or entity with whom they are, or have been, professionally affiliated.